Interferon-induced transmembrane protein 5: Difference between revisions
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{Short description|A protein involved in immune response}} | ||
'''Interferon-induced transmembrane protein 5''' is a | '''Interferon-induced transmembrane protein 5''' (IFITM5) is a member of the [[interferon-induced transmembrane protein]] family, which plays a crucial role in the [[immune response]] to [[viral infections]]. IFITM5 is particularly notable for its involvement in [[bone development]] and [[osteogenesis]]. | ||
== | ==Structure== | ||
IFITM5 is a small transmembrane protein that is part of the larger family of interferon-induced transmembrane proteins. These proteins are characterized by their ability to integrate into cellular membranes and influence cellular processes. IFITM5 contains a conserved [[transmembrane domain]] that allows it to embed in the [[cell membrane]], where it can interact with other cellular components. | |||
The | ==Function== | ||
The primary function of IFITM5 is associated with [[bone mineralization]] and the regulation of [[osteoblast]] activity. Osteoblasts are specialized cells responsible for the formation of new bone tissue. IFITM5 is expressed predominantly in [[osteoblasts]] and is thought to play a role in the early stages of bone formation. | |||
In addition to its role in bone development, IFITM5, like other members of the IFITM family, may also contribute to the cellular defense against viral infections. The IFITM proteins are known to inhibit the entry of certain viruses into host cells, thereby preventing infection and spread. | |||
== | ==Clinical Significance== | ||
Mutations in the IFITM5 gene have been linked to [[osteogenesis imperfecta]], a genetic disorder characterized by fragile bones that break easily. This condition, also known as "brittle bone disease," can vary in severity and is often associated with other symptoms such as [[hearing loss]] and [[dental issues]]. | |||
The | The specific mutation in IFITM5 that is commonly associated with osteogenesis imperfecta is a single nucleotide change that leads to the production of an abnormal protein. This mutation disrupts the normal function of IFITM5 in bone formation, leading to the clinical manifestations of the disease. | ||
== | ==Research== | ||
Ongoing research is focused on understanding the precise mechanisms by which IFITM5 influences bone development and how its dysfunction leads to osteogenesis imperfecta. Studies are also exploring the broader role of IFITM proteins in immune defense and their potential as therapeutic targets for viral infections. | |||
==Related pages== | |||
* [[Interferon-induced transmembrane protein family]] | |||
* [[Osteogenesis imperfecta]] | |||
* [[Osteoblast]] | |||
* [[Bone mineralization]] | |||
[[Category:Proteins]] | |||
[[Category:Immune system]] | |||
[[Category:Bone development]] | |||
[[Category: | |||
[[Category: | |||
[[Category: | |||
Latest revision as of 19:06, 22 March 2025
A protein involved in immune response
Interferon-induced transmembrane protein 5 (IFITM5) is a member of the interferon-induced transmembrane protein family, which plays a crucial role in the immune response to viral infections. IFITM5 is particularly notable for its involvement in bone development and osteogenesis.
Structure[edit]
IFITM5 is a small transmembrane protein that is part of the larger family of interferon-induced transmembrane proteins. These proteins are characterized by their ability to integrate into cellular membranes and influence cellular processes. IFITM5 contains a conserved transmembrane domain that allows it to embed in the cell membrane, where it can interact with other cellular components.
Function[edit]
The primary function of IFITM5 is associated with bone mineralization and the regulation of osteoblast activity. Osteoblasts are specialized cells responsible for the formation of new bone tissue. IFITM5 is expressed predominantly in osteoblasts and is thought to play a role in the early stages of bone formation.
In addition to its role in bone development, IFITM5, like other members of the IFITM family, may also contribute to the cellular defense against viral infections. The IFITM proteins are known to inhibit the entry of certain viruses into host cells, thereby preventing infection and spread.
Clinical Significance[edit]
Mutations in the IFITM5 gene have been linked to osteogenesis imperfecta, a genetic disorder characterized by fragile bones that break easily. This condition, also known as "brittle bone disease," can vary in severity and is often associated with other symptoms such as hearing loss and dental issues.
The specific mutation in IFITM5 that is commonly associated with osteogenesis imperfecta is a single nucleotide change that leads to the production of an abnormal protein. This mutation disrupts the normal function of IFITM5 in bone formation, leading to the clinical manifestations of the disease.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which IFITM5 influences bone development and how its dysfunction leads to osteogenesis imperfecta. Studies are also exploring the broader role of IFITM proteins in immune defense and their potential as therapeutic targets for viral infections.
